1 Ruppert L, Køster B, Siegert AM, Cop C, Boyers L, Karimkhani C, et al. YouTube as a source of health information: Analysis of sun protection and skin cancer prevention related issues. Dermatol Online J. 2017;23(1). pii: 13030/qt91401264. PMID: 28329465.
2 Reinau D, Villa S, Meier CR, Surber C. Internet forums as an information source on sun protection. J Dtsch Dermatol Ges. 2016;14(1):64–6. doi: 10.1111/ddg.12711.
3 Reinau D, Meier CR, Blumenthal R, Surber C. Skin Cancer Prevention, Tanning and Vitamin D: A Content Analysis of Print Media in Germany and Switzerland. Dermatology. 2016;232(1):2–10. doi: 10.1159/000435913.
4 Wang SQ, Goulart JM, Lim HW. Lack of UV-A protection in daily moisturizing creams. Arch Dermatol. 2011;147(5):618–20. doi: 10.1001/archdermatol.2010.406.
5 Surber C. Sonnenschutz – Update. SZD. 2014;3:1–4
6 Stahl W, Sies H. Mol Nutr Food Res. Photoprotection by dietary carotenoids: concept, mechanisms, evidence and future development. 2012;56(2):287–95. doi: 10.1002/mnfr.201100232.
7 Stahl W, Sies H. β-Carotene and other carotenoids in protection from sunlight. Am J Clin Nutr. 2012;96(5):1179–84.
doi: 10.3945/ajcn.112.034819.
8 Köpcke W, Krutmann J. Protection from sunburn with beta-Carotene – a meta-analysis. Photochem Photobiol. 2008;84(2):284–8. PMID: 18086246.
9 Meinke MC, Friedrich A, Tscherch K, Haag SF, Darvin ME, Vollert H, et al. Influence of dietary carotenoids on radical scavenging capacity of the skin and skin lipids. Eur J Pharm Biopharm. 2013;84(2):365–73. doi: 10.1016/j.ejpb.2012.11.012.
10 Gonzalez S, Gilaberte Y, Philips N. Mechanistic insights in the use of a Polypodium leucotomos extract as an oral and topical photoprotective agent. Photochem Photobiol Sci. 2010;9(4):559–63. doi: 10.1039/b9pp00156e.
11 Fabrikant J, Touloei K, Brown SM. A review and update on melanocyte stimulating hormone therapy: afamelanotide. J Drugs Dermatol. 2013;12(7):775–9. PMID: 23884489.
12 Kim ES, Garnock-Jones KP. Afamelanotide: A Review in Erythropoietic Protoporphyria. Am J Clin Dermatol. 2016;17(2):179–85. doi: 10.1007/s40257-016-0184-6.
13 Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329(16):1147–51. PMID: 8377777.
14 Lin JS, Eder M, Weinmann S, Zuber SP, Beil TL, Plaut D, Lutz K. Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 U.S. Preventive Services Task Force Recommendation [Internet]. Ann Intern Med. 2011;154:190–201. PMID: 21542545.
15 Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257–63. doi: 10.1200/JCO.2010.28.7078.
16 Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781–90. doi: 10.7326/0003-4819-158-11-201306040-00002.
17 Lehmann P, Schwarz T. Photodermatoses: diagnosis and treatment. Dtsch Arztebl Int. 2011;108(9):135–41.
doi: 10.3238/arztebl.2011.0135
18 Schleyer V, Weber O, Yazdi A, Benedix F, Dietz K, Röcken M, Berneburg M. Prevention of polymorphic light eruption with a sunscreen of very high protection level against UVB and UVA radiation under standardized photodiagnostic conditions. Acta Derm Venereol. 2008;88(6):555–60. doi: 10.2340/00015555-0509.
19 Patsinakidis N, Wenzel J, Landmann A, Koch R, Gerß J, Luger TA, et al. Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls. Exp Dermatol. 2012;21(12):958–61. doi: 10.1111/exd.12035.
20 Kuhn A, Wenzel J, Bijl M. Lupus erythematosus revisited. Semin Immunopathol. 2016;38(1):97–112. doi: 10.1007/s00281-015-0550-0.
21 Stamatas GN, Nikolovski J, Luedtke MA, Kollias N, Wiegand BC. Infant skin microstructure assessed in vivo differs from adult skin in organization and at the cellular level. Pediatr Dermatol. 2010;27(2):125–31. doi: 10.1111/j.1525-1470.2009.00973.x.
22 Volkmer B, Greinert R. UV and children’s skin. Prog Biophys Mol Biol. 2011;107(3):386–8. doi: 10.1016/j.pbiomolbio.2011.08.011.
23 Cox NH, Diffey BL, Farr PM. The relationship between chronological age and the erythemal response to ultraviolet B radiation. Br J Dermatol. 1992;126(4):315–9. PMID: 1571251.
24 Gilchrest BA. Molecular aspects of tanning. J Invest Dermatol. 2011;131(E1):E14–7. doi: 10.1038/skinbio.2011.6.
25 Mack MC, Tierney NK, Ruvolo E Jr, Stamatas GN, Martin KM, Kollias N. Development of solar UVR-related pigmentation begins as early as the first summer of life. J Invest Dermatol. 2010;130(9):2335–8. doi: 10.1038/jid.2010.104.
26 Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev. 2007;16(5):991–7. PMID: 17507627.
27 Veierød MB, Adami HO, Lund E, Armstrong BK, Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev. 2010;19(1):111–20. doi: 10.1158/1055-9965.
28 Quatrano NA, Dinulos JG. Current principles of sunscreen use in children. Curr Opin Pediatr. 2013;25(1):122–9.
doi: 10.1097/MOP.0b013e32835c2b57.
29 Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, Martin N, Green A. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer. 2002 Mar 1;98(1):92–8. PMID: 11857391.
30 Reinau D, Meier C, Gerber N, Hofbauer GF, Surber C. Sun protective behaviour of primary and secondary school students in North-Western Switzerland. Swiss Med Wkly. 2012;142:w13520. doi: 10.4414/smw.2012.13520]
31 Reinau D, et al. The meaning and implication of sun protection factor. Br J Dermatol. 2015;173(5):1345. doi: 10.1111/bjd.14015.
32 www.youtube.com/watch?v=8cc8qRr7oMQ
33 THE WALL STREET JOURNAL, 11./12. Juli 2015.
34 ISO 24444:2010 Cosmetics –protection test methods – In vivo determination of the sun protection factor (SPF).
35 Standard EN ISO 24442:2011 Cosmetics – Sun protection test methods – in vivo determination of sunscreen UVA protection.
36 Standard EN ISO 24443:2012 Cosmetics – Determination of sunscreen UVA photoprotection in vitro.
37 Schroeder P, Krutman J. IRA-Schutz: Notwendigkeit und Möglichkeiten. Hautarzt. 2009;60(4):301–4.
doi: 10.1007/s00105-008-1626-8.
38 Grether-Beck S, Marini A, Jaenicke T, Krutmann J. Effective photoprotection of human skin against infrared A radiation by topically applied antioxidants: results from a vehicle controlled, double-blind, randomized study. Photochem Photobiol. 2015;91(1):248–50. doi: 10.1111/php.12375.
39 Diffey B. An appraisal of the need for infrared radiation protection in sunscreens. Photochem Photobiol Sci. 2016;15(3):361–4. doi: 10.1039/c5pp00451a
40 COLIPA – The European Cosmetic Toiletry and Perfumery Association. Guideline for evaluation sun product water resistance, Belgium. December 2005.
41 http://www.nationalacademies.org/hmd/Reports/2010/Dietary-%C2%ADReference-%C2%ADIntakes-for-Calcium-and-Vitamin-D.aspx
42 Holick MF. Vitamin D deficiency. NEJM. 2007;357:266–81. PMID: 17634462.
43 Rabenberg M, et al. Vitamin D status among adults in Germany – results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health. 2015;15:641. doi: 10.1186/s12889-015-2016-7.
44 Merlo C, Trummler M, Essig S, Zeller A. Vitamin D Deficiency in Unselected Patients from Swiss Primary Care: A Cross-Sectional Study in Two Seasons. PLoS One. 2015 Sep 15;10(9):e0138613. doi: 10.1371/journal.pone.0138613.
45 van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):671–80.
doi: 10.1016/j.beem.2011.06.007.
46 Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A. Low vitamin D status and obesity: Role of nutritionist. Rev Endocr Metab Disord. 2017 Feb 23. doi: 10.1007/s11154-017-9410-7.
47 Holick MF. Vitamin D deficiency. NEJM. 2007;357:266–81. PMID: 17634462
48 Holick MF. Evolution and function of vitamin D. Recent Results Cancer Res. 2003;164:3–28. PMID: 12899511.
49 Reichrath J. Protecting against adverse effects of sun protection. J Am Acad Dermatol. 2003;49(6):1204–6. PMID: 14639432.
50 http://monographs.iarc.fr/ENG/Classification/index.php
51 El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens – part D: radiation. Lancet Oncol. 2009;10(8):751–2. PMID: 19655431.
52 Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165–8. PMID: 3033008.
53 Matsuoka LY, Wortsman J, Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol. 1988;124(12):1802–4. PMID: 3190255.
54 Matsuoka LY, Wortsman J, Hollis BW. Use of topical sunscreen for the evaluation of reginal synthesis of vitamin D3. J Am Acad Dermatol. 1990;22:772–5. PMID: 2161436.
55 Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC. The effect of regular sunscreen use on vitamin D levels in an Australian population. Arch Dermatol 1995;131:415–21. PMID: 7726582.
56 Marks R. Sunlight and health. Use of sunscreen does not risk vitamin D deficiency. BMJ. 1999;319:1066. PMID: 10521210.
57 Farrerons J, Barnadas M, Rodríguez J, Renau A, Yoldi B, López-Navidad A, Moragas J. Clinically prescribed sunscreen (SPF 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. Br J Dermatol. 1998;139:422–7. PMID: 9767286.
58 Farrerons J, Barnadas M, López-Navidad A, Renau A, Rodríguez J, Yoldi B, Alomar A. Sunscreen and risk of osteoporosis in the elderly: a two-year follow-up. Dermatology. 2001;202:27–30. PMID: 11244224.
59 Harris SS, Dawson-Hughes B. Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults. J Clin Endocrin Metab. 2007;92:3155–7. PMID: 17535990.
60 Kligman EW, Watkins A, Johnson K, Kronland R. The impact of lifestyle factors on serum 25 hydroxy vitamin D levels in older adults: a preliminary study. Fam Pract Res. 1989;9:11–9. PMID: 2610008.
61 Kimlin M, Harrison S, Nowak M, Moore M, Brodie A, Lang C. Does a high UV Environment ensure adequate vitamin D status? J Photochem Photobiol Biol. 2007;89:139–47. PMID: 17964181.
62 Cusack C, Danby C, Fallon JC, Ho WL, Murray B, Brady J, et al. Photoprotective behaviour and sunscreen use: impact on Vitamin D levels in cutaneoous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2008;24:260–7. doi: 10.1111/j.1600-0781.2008.00373.x.
63 Thieden E, Philipsen PA, Sandby-Møller J, Wulf HC. Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun exposure behaviour diaries. Arch Dermatol. 2005;141:967–73. PMID: 16103325.
64 Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76–89. doi: 10.1016/S2213-8587(13)70165-7.
65 DIE WELT, 28. September 2009 (http://www.welt.de/gesundheit/article4208429/Nano-klingt-cool-und-kann-so-schaden-wie-Asbest.html)
66 Martin J, Bello D, Bunker K, Shafer M, Christiani D, Woskie S, Demokritou P. Occupational exposure to nanoparticles at commercial photocopy centers. J Hazard Mater. 2015;298:351–60. doi: 10.1016/j.jhazmat.2015.06.021.
67 Carlotti ME, Ugazio E, Sapino S, Fenoglio I, Greco G, Fubini B. Role of particle coating in controlling skin damage photoinduced by titania nanoparticles. Free Radic Res. 2009;43(3):312–22. doi: 10.1080/10715760802716633.
68 Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol. 2007;37(3):251–77. PMID: 17453934.
69 Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, Pape W, et al. Human safety review of «nano» titanium dioxide and zinc oxide. Photochem Photobiol Sci. 2010;9:495–509. doi: 10.1039/b9pp00180h.
70 Leite-Silva VR, Sanchez WY, Studier H, Liu DC, Mohammed YH, Holmes AM, et al. Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment. Eur J Pharm Biopharm. 2016;104:140–7.
doi: 10.1016/j.ejpb.2016.04.022.
71 Witorsch RJ, Thomas JA. Personal care products and endocrine disruption: A critical review of the literature. Crit Rev Toxicol. 2010 Nov;40 Suppl 3:1–30. doi: 10.3109/10408444.2010.515563.
72 Kim S, Choi K. Occurrences, toxicities, and ecological risks of benzophenone-3, a common component of organic sunscreen products: a mini-review. Environ Int. 2014 Sep;70:143–57. doi: 10.1016/j.envint.2014.05.015.
73 Zamoiski RD, Cahoon EK, Michal Freedman D, Linet MS. Self-reported sunscreen use and urinary benzophenone-3 concentrations in the United States: NHANES 2003–2006 and 2009–2012. Environ Res. 2015;142:563–7.
doi: 10.1016/j.envres.2015.08.006.
74 Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol. 2009;161 Suppl 3:78–84. doi: 10.1111/j.1365-2133.2009.09453.x.
75 Zahn S, Graef M, Patsinakidis N, Landmann A, Surber C, Wenzel J, Kuhn A. Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. Exp Dermatol. 2014;23(7):516–8.
doi: 10.1111/exd.12428.